• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Model Number ETBF3216C166E
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/21/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Continuation of d10: section d information references the main component of the system.Other relevant device(s) are: product id: etlw1616c124e, serial/lot #: (b)(6), ubd: 19-jul-2015, udi#: (b)(4).Film evaluation summary: the reported type ia endoleak was likely confirmed on the films provided; however the cause of the event could not be conclusively determined.Complete post-implant cts were also not available for a more thorough assessment of the event.The pre-implant anatomy is unknown and earlier post implant cts were not available for comparison of the stent graft configuration in vivo overtime.Lack of total seal and apposition of the distal left limb was observed without evidence of type ib endoleak.It is possible that disease progression with aneurysm morphology changes overt the 10 years since implantation may have contributed to this event, but this could not be confirmed.Analysis of the available films did not review any obvious stent graft integrity issues.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
An endurant ii stent graft (etbf3216c166e) and endurant limb (etlw1616c124e) was implanted during the endovascular treatment of an a bdominal aortic aneurysm on (b)(6) 2013.It was reported on (b)(6) 2024, follow-up imaging identified a type ia endoleak.Per the physician the cause of the type ia endoleak is undetermined.No additional clinical sequelae were reported, and the patient will be monitored.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19087533
Report Number9612164-2024-01743
Device Sequence Number20614979
Product Code MIH
UDI-Device Identifier00613994990990
UDI-Public00613994990990
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2013
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/03/2015
Device Model NumberETBF3216C166E
Device Catalogue NumberETBF3216C166E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/26/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/21/2024
Initial Report FDA Received Date04/11/2024
Date Device Manufactured07/03/2013
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
"SEE H11...."
Patient Age81 YR
Patient SexMale
-
-